Over 38.4 million people were living with HIV globally in 2021. The HIV continuum includes HIV testing, diagnosis, linkage to combined antiretroviral therapy (cART), and retention in …
M Metra, EA Jankowska, M Pagnesi… - European journal of …, 2022 - Wiley Online Library
Aims In AFFIRM‐AHF, intravenous ferric carboxymaltose (FCM) reduced heart failure (HF) hospitalisations and improved quality of life versus placebo in iron‐deficient patients …
L Wei, E Butterly, JR Pérez, A Chowdhury, R Shemilt… - BMJ …, 2024 - bmjopen.bmj.com
Introduction In trials, subgroup analyses are used to examine whether treatment effects differ by important patient characteristics. However, which subgroups are most commonly reported …
S Nemati, B Mohammadi… - Journal of Clinical …, 2024 - Wiley Online Library
Background Heart failure (HF) is a common condition that imposes a significant burden on healthcare systems. We aimed to identify subgroups of patients with heart failure admitted to …
H Rodríguez-Ramallo, N Báez-Gutiérrez… - Journal of Personalized …, 2022 - mdpi.com
Pulmonary hypertension (PH) treatment decisions are driven by the results of randomized controlled trials (RCTs). Subgroup analyses are often performed to assess whether the …
Context and objective Randomised controlled trials (hereafter, trials) are widely regarded as the gold standard for evaluating treatment efficacy in medical interventions. They employ …
We appreciate the interest shown by Shaw et al. in our manuscript. The authors raise several important points that we hope to address. First, the authors ask us to define what is …
H Rodríguez-Ramallo, N Báez-Gutiérrez… - 2021 - pdfs.semanticscholar.org
Background. Pulmonary hypertension (PH) treatment decisions are driven by randomized controlled trials (RCTs) results. Subgroup analyses are often performed to assess whether …